Categories
Faculty News

Bill Wuest part of team using AI to develop next-generation disinfectants

he National Science Foundation has awarded $800,000 to a team including Emory chemist William Wuest that will use artificial intelligence to develop next-generation disinfectants against resistant bacteria. Continue readingBill Wuest part of team using AI to develop next-generation disinfectants

Categories
News PhD Program News

Graduate alumni Green and Solinski selected as 2023 CAS Future Leaders

Chemistry graduate program alumni Mallory Green and Amy Solinski have been selected as 2023 CAS Future Leaders. Continue readingGraduate alumni Green and Solinski selected as 2023 CAS Future Leaders

Categories
Faculty News Grants and Awards News

Monika Raj named National Academy of Sciences Kavli Fellow

Monika Raj has been named a 2023 Kavli Fellow by the National Academy of Sciences.Continue readingMonika Raj named National Academy of Sciences Kavli Fellow

Categories
Faculty News News

Liebeskind selected as interim senior vice provost for academic affairs

Chemistry professor and vice-provost Lanny Liebeskind will serve as interim senior vice provost for academic affairs, beginning September 1, 2022.Continue readingLiebeskind selected as interim senior vice provost for academic affairs

Categories
News

Alum Lilly D’Angelo receives 2022 Sheth Distinguished International Alumni Award

Continue readingAlum Lilly D’Angelo receives 2022 Sheth Distinguished International Alumni Award

Categories
News

Molnupiravir and Drug Development at Emory

Molnupiravir is currently being developed by Merck & Co. Inc. in collaboration with Ridgeback Biotherapeutics, which licensed the drug from DRIVE (founded by Emory chemist Dennis Liotta) in 2020. It could be the first oral antiviral medicine to treat COVID-19. Continue readingMolnupiravir and Drug Development at Emory

Categories
Careers

Graduate alum Xiaohu Deng named head of technical operations at Vividion Therapeutics

Liebeskind Group alum Xiaohu Deng has been named head of technical operations at Vividion Therapeutics, a biotechnology company focused on small molecule therapeutics for multiple highly sought-after disease-modifying target proteins in oncology and immunology.Continue readingGraduate alum Xiaohu Deng named head of technical operations at Vividion Therapeutics

Categories
News

Andrew Mahoney receives ACS Medicinal Chemistry Predoctoral Fellowship

Graduate Scholar Andrew Mahoney has been awarded a 2021-2022 ACS Medicinal Chemistry Predoctoral Fellowship, an achievement he describes in quirky fashion in his brief autobiography.Continue readingAndrew Mahoney receives ACS Medicinal Chemistry Predoctoral Fellowship

Categories
Research

Raj Group chemists develop tools that may help improve cancer diagnostics, therapeutics

Continue readingRaj Group chemists develop tools that may help improve cancer diagnostics, therapeutics

Categories
News

Chemistry celebrates six NSF GRFP awards and four honorable mentions

The Department of Chemistry is celebrating five NSF Graduate Research Fellowship awards and four honorable mentions in the 2021 competition.Continue readingChemistry celebrates six NSF GRFP awards and four honorable mentions

Categories
News

Monika Raj selected as 2021 Thieme Chemistry Journal Awardee

Monika Raj has been selected by the editorial boards of Synlett, Synthesis, and Synfacts  as a 2021 Thieme Chemistry Journal Awardee. This annual award recognizes promising professors at the beginning of their independent academic career. Awardees receive free print and electronic subscriptions of all three journals as a gesture of encouragement. Monika joined the Emory faculty in August…Continue readingMonika Raj selected as 2021 Thieme Chemistry Journal Awardee

Categories
Community

A Conversation with Spandan Chennamadhavuni

While we are socially distant, we are working to bring the chemistry community closer together by sharing conversations with faculty, students, staff, and alumni. Interviews were conducted electronically and have been lightly edited for readability.Continue readingA Conversation with Spandan Chennamadhavuni